-
Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch
12 Jan 2024 18:15 GMT
… Announcement
PITTSBURGH – Jan. 18, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is …
-
Global Retinoid Market Poised for Growth, Expected to Reach US$ 3.05 Billion by 2034 at a moderate CAGR of 6.5% | Future Market Insights
15 Apr 2024 17:30 GMT
… market:-
In September 2019, Mylan Pharmaceuticals Inc. and Eisai India entered …
Key Companies Profiled
GlaxoSmithKline Inc.
Mylan Pharmaceuticals Inc.
Sun Pharmaceutical Industries Ltd …
-
Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch
27 Oct 2023 15:09 GMT
… on some vials
Company Name:
Mylan Pharmaceuticals, Inc. a Viatris Company
Brand … - PITTSBURGH – April 12, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is …
-
Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)
14 Sep 2023 04:14 GMT
… Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc.
The case arose in … inter partes review initiated by Mylan Pharmaceuticals over Reissue Patent No. RE47 … ).
Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)
Panel …
-
Amyotrophic Lateral Sclerosis Treatment Market Expected to Expand at a Steady 2024-2031 | Sanofi S.A.
10 Apr 2024 10:58 GMT
… Company Ltd.
◘ Sanofi S.A.
◘ Mylan Pharmaceuticals Inc.
The detailed segments and …
-
Genital Herpes Treatment Market Still Going Strong | Novartis, Mylan Pharmaceuticals, Teva Pharmaceuticals
31 Oct 2022 20:33 GMT
… , Vical, Maruho, Teva Pharmaceuticals Inc, Mylan Pharmaceuticals Inc., Apotheca Inc., Sandoz Inc … , Vical, Maruho, Teva Pharmaceuticals Inc, Mylan Pharmaceuticals Inc., Apotheca Inc., Sandoz Inc …
-
Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp. (Fed. Cir. 2022)
06 Oct 2022 04:44 GMT
… inter partes review (IPR) that Mylan Pharmaceuticals failed to show the claims … the asserted prior art, in Mylan Pharmaceuticals Inc. v. Merck Sharp … institution in the first place).
Mylan Pharmaceuticals Inc. v. Merck Sharp …
-
Mylan Pharmaceuticals recalls insulin glargine injection pens for potential missing labels
08 Jul 2022 02:51 GMT
… @slackinc.com.
Back to Healio
Mylan Pharmaceuticals has issued a voluntary recall … .
This is the second recall Mylan Pharmaceuticals has issued in less than … missing label on some vials.
Mylan Pharmaceuticals has notified its distributors and …
-
Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some Pens
07 Jun 2022 09:56 GMT
… .
Company Name:
Mylan Pharmaceuticals Inc.
Brand Name:
Brand Name(s)
Mylan Pharmaceuticals Inc.
Product … - PITTSBURGH – July 5, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is …
-
Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some Pens
07 Jun 2022 09:56 GMT
… .
Company Name:
Mylan Pharmaceuticals Inc.
Brand Name:
Brand Name(s)
Mylan Pharmaceuticals Inc.
Product … - PITTSBURGH – July 5, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is …